State Key Laboratory of Military Stomatology and National Clinical Research Center for Oral Diseases and Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an 710032, PR China; School of Stomatology, Southern Medical University, Nanfang Hospital, Southern Medical University, Guangzhou 510515, PR China.
State Key Laboratory of Military Stomatology and National Clinical Research Center for Oral Diseases and Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an 710032, PR China.
Acta Biomater. 2018 Nov;81:129-145. doi: 10.1016/j.actbio.2018.10.005. Epub 2018 Oct 6.
Cartilaginous extracellular matrix (ECM) materials derived from decellularized native articular cartilage are widely used in cartilage regeneration. However, it is difficult for endogenous cells to migrate into ECM derived from native cartilage owing to its nonporous structure and dense nature. Moreover, current decellularization approaches frequently lead to architectural breakdown and potential loss of surface composition of ECM. To solve this problem, we aimed to establish a novel biological ECM scaffold from chondrocyte sheets for cartilage regeneration. We cultured chondrocytes harvested from the auricular cartilage of 4-week-old New Zealand rabbits and enabled them to form cell sheets. These sheets were decellularized using sodium dodecyl sulfate (SDS) with three different concentrations, namely, 1%, 5%, and 10%, followed by 1% Triton X-100 and deoxyribonuclease enzyme solution. In vitro microstructural examination and mechanical tests demonstrated that 1% SDS not only removed chondrocytes completely but also maintained the native architecture and composition of ECM, thus avoiding the use of high-concentration SDS. Application of decellularized chondrocyte sheets for osteochondral defects in rabbits resulted in substantial host remodeling and variant regeneration of osteochondral tissues. One percent SDS-treated decellularized chondrocyte sheets contributed to the superior reconstruction of osteochondral defects as compared with 5% and 10% SDS groups, which includes vascularized subchondral bone, articular cartilage with adequate thickness, and integration with host tissues. Furthermore, ECM from 1% SDS significantly increased the migrating potential of bone marrow mesenchymal stem cells (BMSCs) in vitro. RT-PCR and western blot also revealed that ECM increased the expression of SOX-9 in BMSCs, whereas it decreased COL-X expression. In conclusion, our results suggested that the chondrocyte sheets decellularized with 1% SDS preserved the integrity and bioactivity, which favored cell recruitment and enabled osteochondral regeneration in the knee joints of rabbits, thus offering a promising approach for articular cartilage reconstruction without cell transplantation. STATEMENT OF SIGNIFICANCE: Although biological extracellular matrix (ECM) derived from decellularized native cartilage has been widely used in cartilage regeneration, it is difficult for endogenous cells to migrate into ECM owing to its dense nature. Moreover, current decellularization approaches lead to architectural breakdown of ECM. This study established a novel biological ECM from decellularized chondrocyte sheets for cartilage regeneration. Our results suggested that cartilaginous ECM favored cell recruitment and enabled osteochondral regeneration in rabbits, thus offering a promising approach for articular cartilage reconstruction without cell transplantation. SDS 1% adequately decellularized the chondrocytes in cell sheets, whereas it maintained the native architecture and composition of ECM, thereby avoiding the use of high-concentration SDS and providing a new way to acquire cartilaginous ECM.
软骨细胞外基质 (ECM) 材料来源于脱细胞化的天然关节软骨,广泛用于软骨再生。然而,由于其非多孔结构和致密性质,内源性细胞很难迁移到源自天然软骨的 ECM 中。此外,目前的脱细胞方法经常导致 ECM 的结构破坏和潜在的表面成分丢失。为了解决这个问题,我们旨在从软骨细胞片建立一种新型的生物 ECM 支架用于软骨再生。我们培养从小兔耳软骨中收获的软骨细胞,使其形成细胞片。然后使用三种不同浓度的十二烷基硫酸钠 (SDS)(1%、5%和 10%)对这些片进行脱细胞处理,然后使用 1% Triton X-100 和脱氧核糖核酸酶溶液。体外微观结构检查和力学测试表明,1% SDS 不仅能完全去除软骨细胞,还能保持 ECM 的天然结构和组成,从而避免使用高浓度 SDS。脱细胞化的软骨细胞片在兔的骨软骨缺损中的应用导致宿主的大量重塑和骨软骨组织的不同再生。与 5%和 10% SDS 组相比,1% SDS 处理的脱细胞化软骨细胞片有助于更好地重建骨软骨缺损,包括血管化的软骨下骨、具有足够厚度的关节软骨以及与宿主组织的整合。此外,1% SDS 的 ECM 显著增加了骨髓间充质干细胞 (BMSCs) 在体外的迁移潜力。RT-PCR 和 Western blot 还表明,ECM 增加了 BMSCs 中 SOX-9 的表达,而降低了 COL-X 的表达。总之,我们的结果表明,用 1% SDS 脱细胞化的软骨细胞片保留了完整性和生物活性,有利于细胞募集,并促进了兔膝关节的骨软骨再生,从而为无需细胞移植的关节软骨重建提供了一种有前途的方法。
意义声明:尽管来源于脱细胞化天然软骨的生物细胞外基质 (ECM) 已广泛用于软骨再生,但由于其致密性质,内源性细胞很难迁移到 ECM 中。此外,目前的脱细胞方法导致 ECM 的结构破坏。本研究建立了一种新型的生物 ECM 用于软骨再生,由脱细胞化的软骨细胞片组成。我们的结果表明,软骨细胞外基质有利于细胞募集,并促进了兔的骨软骨再生,从而为无需细胞移植的关节软骨重建提供了一种有前途的方法。SDS 1% 足以脱细胞化细胞片上的软骨细胞,同时保持 ECM 的天然结构和组成,从而避免使用高浓度 SDS,并提供了一种获得软骨细胞外基质的新方法。
Stem Cell Res Ther. 2025-6-17
Bioimpacts. 2024-10-26
Front Bioeng Biotechnol. 2024-8-2
J Tissue Eng. 2023-3-31
Chin Med J (Engl). 2023-9-5
Int J Mol Sci. 2022-9-22